Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol

Liver Transplantation

Volumn 20, Issue 8, 2014, Pages 1000-1011

  Nativ, Nir I ^a   Yarmush, Gabriel ^a   So, Ashley ^a   Barminko, Jeffery ^a   Maguire, Timothy J ^a   Schloss, Rene ^a   Berthiaume, Francois ^a   Yarmush, Martin L ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CARNITINE; FAT DROPLET; KETONE BODY; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UREA; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; FATTY ACID OXIDATION; HYPEROXIA; HYPOXIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER CELL CULTURE; MACROSTEATOTIC HEPATOCYTE; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REOXYGENATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANOXIA; BLOOD; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FATTY LIVER; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; METABOLISM; PATHOLOGY; PERFUSION; PROCEDURES; REPERFUSION INJURY; ZUCKER RAT;

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; CARNITINE; CYTOSOL; FATTY LIVER; HEPATOCYTES; KETONE BODIES; L-LACTATE DEHYDROGENASE; LIVER TRANSPLANTATION; MALE; MITOCHONDRIA; OXYGEN; PERFUSION; RATS; RATS, ZUCKER; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; TRANSPLANTATION CONDITIONING; TRIGLYCERIDES;

EID: 84905123817     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23905     Document Type: Article

References (41)

1. de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol 2012; 27: 540-546.
2. Guarrera JV, Henry SD, Chen SW, Brown T, Nachber E, Arrington B, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 2011; 167: e365-e373.
3. Henry SD, Nachber E, Tulipan J, Stone J, Bae C, Reznik L, et al. Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 2012; 12: 2477-2486.
4. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874-884.
5. Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML,. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 2009; 152: 54-60.
6. Nativ NI, Maguire TJ, Yarmush G, Brasaemle DL, Henry SD, Guarrera JV, et al. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant 2012; 12: 3176-3183.
7. Selzner N, Selzner M, Jochum W, Amann-Vesti B, Graf R, Clavien PA,. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol 2006; 44: 694-701.
8. Berendsen TA, Izamis ML, Xu H, Liu Q, Hertl M, Berthiaume F, et al. Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts. Transplant Proc 2011; 43: 1484-1488.
9. Laurens M, Scozzari G, Patrono D, St-Paul MC, Gugenheim J, Huet PM, Crenesse D,. Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver. Liver Transpl 2006; 12: 217-225.
10. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S,. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc 1997; 29: 412-415.
11. Vairetti M, Ferrigno A, Carlucci F, Tabucchi A, Rizzo V, Boncompagni E, et al. Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase? Liver Transpl 2009; 15: 20-29.
12. Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608-612.
13. Nativ NI, Yarmush G, Chen A, Dong D, Henry SD, Guarrera JV, et al. Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function. J Hepatol 2013; 59: 1307-1314.
14. Nagrath D, Xu H, Tanimura Y, Zuo R, Berthiaume F, Avila M, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng 2009; 11: 274-283.
15. Lankester DL, Brown AM, Zammit VA,. Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty acid for the synthesis of triacylglycerol secreted by cultured rat hepatocytes. J Lipid Res 1998; 39: 1889-1895.
16. Keller J, Ringseis R, Priebe S, Guthke R, Kluge H, Eder K,. Effect of l -carnitine on the hepatic transcript profile in piglets as animal model. Nutr Metab (Lond) 2011; 8: 76.
17. Murosaki S, Lee TR, Muroyama K, Shin ES, Cho SY, Yamamoto Y, Lee SJ,. A combination of caffeine, arginine, soy isoflavones, and l -carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J Nutr 2007; 137: 2252-2257.
18. Ramaiah SK,. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol 2007; 45: 1551-1557.
19. Nakajima T, Horiuchi M, Yamanaka H, Kizaki Z, Inoue F, Kodo N, et al. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr Res 1997; 42: 108-113.
20. Giannone FA, Treré D, Domenicali M, Grattagliano I, Baracca A, Sgarbi G, et al. An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury. ScientificWorldJournal 2012; 2012: 573410.
21. Dunn JC, Tompkins RG, Yarmush ML,. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog 1991; 7: 237-245.
22. Cotter DG, Schugar RC, Crawford PA,. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol 2013; 304: H1060-H1076.
23. Sato C, Saito T, Misawa K, Katsumi T, Tomita K, Ishii R, et al. Impaired mitochondrial β-oxidation in patients with chronic hepatitis C: relation with viral load and insulin resistance. BMC Gastroenterol 2013; 13: 112.
24. Fromenty B, Pessayre D,. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997; 26 (suppl 2): 43-53.
25. Serviddio G, Giudetti AM, Bellanti F, Priore P, Rollo T, Tamborra R, et al. Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS One 2011; 6: e24084.
26. Chen MF, Chen HM, Ueng SW, Shyr MH,. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 1998; 18: 110-116.
27. Tolba RH, Pütz U, Decker D, Dombrowski F, Lauschke H,. l -Carnitine ameliorates abnormal vulnerability of steatotic rat livers to cold ischemic preservation. Transplantation 2003; 76: 1681-1686.
28. Malaguarnera M, Gargante MP, Russo C, Antic T, Vacante M, Malaguarnera M, et al. l -Carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial. Am J Gastroenterol 2010; 105: 1338-1345.
29. Liang LJ, Yin XY, Luo SM, Zheng JF, Lu MD, Huang JF,. A study of the ameliorating effects of carnitine on hepatic steatosis induced by total parenteral nutrition in rats. World J Gastroenterol 1999; 5: 312-315.
30. Li JL, Wang QY, Luan HY, Kang ZC, Wang CB,. Effects of l -carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha. J Biomed Sci 2012; 19: 32.
31. Minor T, Akbar S, Tolba R, Dombrowski F,. Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol 2000; 32: 105-111.
32. Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, et al. Reduced expression of peroxisome proliferator-activated receptor-α may have an important role in the development of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2004; 19: 799-804.
33. Andrieu-Abadie N, Jaffrezou JP, Hatem S, Laurent G, Levade T, Mercadier JJ,. l -Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J 1999; 13: 1501-1510.
34. Serafín A, Rosellõ-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C,. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601.
35. Mokuno Y, Berthiaume F, Tompkins RG, Balis UJ, Yarmush ML,. Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model. Liver Transpl 2004; 10: 264-272.
36. Tomomura M, Tomomura A, Dewan MA, Saheki T,. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action. FEBS Lett 1996; 399: 310-312.
37. Pizarro M, Balasubramaniyan N, Solís N, Solar A, Duarte I, Miquel JF, et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 2004; 53: 1837-1843.
38. Ninomiya M, Shimada M, Terashi T, Ijichi H, Yonemura Y, Harada N, et al. Sustained spatial disturbance of bile canalicular networks during regeneration of the steatotic rat liver. Transplantation 2004; 77: 373-379.
39. Liu Q, Berendsen T, Izamis ML, Uygun B, Yarmush ML, Uygun K,. Perfusion defatting at subnormothermic temperatures in steatotic rat livers. Transplant Proc 2013; 45: 3209-3213.
40. University of Oxford. World first: device keeps human liver alive outside body. http://www.ox.ac.uk/media/news-stories/2013/130315.html. Accessed December 2013.
41. Vogel T, Brockmann JG, Coussios C, Friend PJ,. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev (Orlando) 2012; 26: 156-162.